Search

Your search keyword '"Vaccinia -- Research"' showing total 97 results

Search Constraints

Start Over You searched for: Descriptor "Vaccinia -- Research" Remove constraint Descriptor: "Vaccinia -- Research" Journal vaccine weekly Remove constraint Journal: vaccine weekly
97 results on '"Vaccinia -- Research"'

Search Results

1. Findings from AstraZeneca in Oncolytic Virotherapy Reported (Mediation of Antitumor Activity By Azd4820 Oncolytic Vaccinia Virus Encoding Il-12)

2. Reports from Universitatsklinikum Dusseldorf Add New Data to Research in Vaccinia Virus (Viral Vector-Based * * Chlamydia trachomatis* * Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice)

3. Studies from Transgene SA Provide New Data on Oncolytic Virotherapy (TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment)

4. New Vaccinia Virus Research from Children's Hospital Described (A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by ...)

5. Cornell University Weill Cornell Graduate School of Medical Sciences Researcher Yields New Study Findings on Vaccinia Virus (Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity)

6. Study Findings from Universitatsklinikum Dusseldorf Broaden Understanding of Vaccinia Virus (The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation)

8. Research from University of Washington Yields New Data on Vaccinia [Asymptomatic and Subclinical Mpox: An Association with Modified Vaccinia Ankara (MVA) Vaccine]

10. Studies Conducted at City of Hope National Medical Center on Orthopoxvirus Recently Published (Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus)

11. New Vaccinia Virus Study Findings Have Been Reported from University of Regensburg (Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across ...)

12. Reports Outline Biosensors Findings from Federal University of the Jequitinhonha and Mucuri Valleys [A Low-cost Electrochemical Biosensor for Vaccinia Virus Using Pencil Graphite Electrodes Modified With Poly(Hydroxybenzamide)]

13. Research from Moderna Inc. in the Area of Vaccinia Virus Published (An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge)

14. New Monkeypox Findings from Capital Medical University Described (Cross-reactive Antibodies Against Monkeypox Virus Exist In the Population Immunized With Vaccinia Tian Tan Strain In China)

15. Findings on Vaccinia Virus Detailed by Investigators at Sun Yat-sen University (Mpox Virus Mrna-lipid Nanoparticle Vaccine Candidates Evoke Antibody Responses and Drive Protection Against the Vaccinia Virus Challenge In Mice)

16. City of Hope National Medical Center Details Findings in Vaccinia Virus (Hematopoietic Stem Cell Donor Vaccination With Cytomegalovirus Triplex Augments Frequencies of Functional and Durable Cytomegalovirus-specific T Cells In the Recipient: a ...)

17. Data from University of Connecticut Broaden Understanding of Vaccinia Virus (Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform)

18. Research Results from Department of Veterans Affairs Update Understanding of Vaccinia Virus (A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination)

19. Recent Studies from Boston University Add New Data to Monkeypox (Identification of Small Molecules With Improved Potency Against Orthopoxviruses From Vaccinia To Smallpox)

21. Researchers at Kyung Hee University Report Research in Toxoplasma gondii (Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against * * Toxoplasma gondii* * Challenge Infection)

22. Studies from Duke University Medical Center Reveal New Findings on Vaccinia Virus [Gamma Delta T Cells Are Required for Cd8(+) T Cell Response To Vaccinia Viral Infection]

23. Study Data from Charles University Provide New Insights into Vaccinia Virus (Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism)

25. Researchers at Swansea University Report Research in Vaccinia Virus (Nanopore sequencing and de novo assembly of a misidentified Camelpox vaccine reveals putative epigenetic modifications and alternate protein signal peptides)

26. Studies from University of California San Francisco (UCSF) Describe New Findings in Oncolytic Virotherapy (Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects On Tumor Infection, Immune Response, and Killing)

27. Research from University of Connecticut Yields New Findings on Zika Virus (Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice)

28. Reports from Obihiro University of Agriculture and Veterinary Medicine Highlight Recent Findings in Vaccinia Virus (Construction of a Recombinant Vaccinia Virus Expressing Babesia Gibsoni Thrombospondin-related Anonymous Protein and Evaluation ...)

29. Researchers from Ghent University Detail Findings in Vaccinia Virus (Vaccinia Virus Protein B18R: Influence on mRNA Immunogenicity and Translation upon Non-Viral Delivery in Different Ocular Cell Types)

30. Research on Smallpox Vaccines Discussed by Researchers at Brigham and Women's Hospital (Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge)

31. Researchers from Tottori University Faculty of Medicine Report Findings in Oncolytic Virotherapy (Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment)

32. Recent Findings from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria Has Provided New Data on Vaccinia Virus (Tools for the targeted genetic modification of poxvirus genomes) (Tools for the targeted genetic modification ...)

33. Studies from Tennessee Valley Healthcare System in the Area of Vaccinia Virus Described (Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model)

34. Researchers from Monash University Malaysia Detail New Studies and Findings in the Area of Vaccinia Virus (Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical Trials)

35. Studies Conducted at University of Liverpool on Vaccinia Recently Reported [Modified Vaccinia Ankara-Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T ...]

36. Researchers from Australian National University Report New Studies and Findings in the Area of Vaccinia Virus (Surprisingly Effective Priming of CD8+ T cells by Heat-Inactivated Vaccinia Virus Virions)

37. Research on Vaccinia Virus Reported by Researchers at Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) (Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce ...)

38. Studies from Public Health Agency of Canada in the Area of Vaccinia Virus Described (Application of poxvirus K3 ortholog as a positive selection marker for constructing recombinant vaccinia viruses with modified host range)

39. New Vaccinia Virus Findings from Federal University Minas Gerais Discussed (Short Communication: a Modified Vaccinia Virus Ankara-based Porcine Circovirus 2 Vaccine Elicits Strong Antibody Response Upon Prime-boost Homologous Immunization In a ...)

40. University of New South Wales Researchers Detail New Studies and Findings in the Area of Vaccinia Virus (Serological Immunity to Smallpox in New South Wales, Australia)

41. Findings from Queen Mary University of London Provides New Data about Oncolytic Virotherapy (Transient Inhibition of Pi3k Delta Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus)

42. Research Conducted at University of Connecticut Has Updated Our Knowledge about Vaccinia Virus [EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses]

43. New Fowlpox Virus Findings from Center for Cancer Research Described (Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced ...)

44. Study Results from Dusseldorf University Hospital Provide New Insights into Vaccinia Virus (ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection)

45. Research Results from Indiana University School of Medicine Update Understanding of Oncolytic Virotherapy (Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and ...)

46. Findings in the Area of Vaccinia Virus Reported from Australian National University (Vaccinia Virus Strain MVA can Induce Optimal CD8+ T cell responses to Directly Primed Antigens Depending on Vaccine Design)

47. Study Results from P. Rosenbaum et al Provide New Insights into Attenuated Vaccines (Molecular and Cellular Dynamics in the Skin, the Lymph Nodes, and the Blood of the Immune Response to Intradermal Injection of Modified Vaccinia Ankara Vaccine)

50. New Vaccinia Study Findings Have Been Reported by Researchers at LMU University (Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens)

Catalog

Books, media, physical & digital resources